Plandaí Biotechnology Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep '16 Sep 30, 2016	Jun '16 Jun 30, 2016	Jun '15 Jun 30, 2015	Jun '14 Jun 30, 2014	Jun '13 Jun 30, 2013	Jun '12 Jun 30, 2012
Operating Revenue	0.23	0.19	0.01	0.27	0.36	0.07
Other Revenue	0.1	0.1	0.09	-	-	-
Revenue	0.34	0.3	0.09	0.27	0.36	0.07
Revenue Growth (YoY)	215.33%	221.31%	-65.04%	-26.01%	382.38%	-
Cost of Revenue	0.91	0.94	0.79	0.95	0.96	-
Gross Profit	-0.57	-0.64	-0.69	-0.69	-0.6	0.07
Selling, General & Admin	1.87	1.94	7.74	3.87	1.92	3.88
Operating Expenses	2.38	2.46	8.16	4.06	2.05	3.88
Operating Income	-2.95	-3.11	-8.85	-4.74	-2.66	-3.81
Interest Expense	-1.97	-1.79	-0.93	-1.03	-0.31	-0.03
Other Non Operating Income (Expenses)	-0.02	-0.12	-0	-4.24	-	0
EBT Excluding Unusual Items	-4.93	-5.01	-9.78	-10.01	-2.97	-3.84
Asset Writedown	-	-	-	-5.75	-	-
Other Unusual Items	0.27	0.27	-0.3	-0.28	-	-
Pretax Income	-4.66	-4.74	-10.07	-16.05	-2.97	-3.84
Earnings From Continuing Operations	-4.66	-4.74	-10.07	-16.05	-2.97	-3.84
Minority Interest in Earnings	0.34	0.36	0.49	0.44	0.78	0.06
Net Income	-4.32	-4.38	-9.58	-15.61	-2.19	-3.78
Net Income to Common	-4.32	-4.38	-9.58	-15.61	-2.19	-3.78
Shares Outstanding (Basic)	196	174	137	115	111	96
Shares Outstanding (Diluted)	196	174	137	115	111	96
Shares Change (YoY)	35.33%	27.17%	19.33%	3.45%	15.13%	26.74%
EPS (Basic)	-0.02	-0.03	-0.07	-0.14	-0.02	-0.04
EPS (Diluted)	-0.02	-0.03	-0.07	-0.14	-0.02	-0.04
Free Cash Flow	-1	-1.08	-3.56	-3.32	-3.81	-6.83
Free Cash Flow Per Share	-0.01	-0.01	-0.03	-0.03	-0.03	-0.07
Gross Margin	-168.10%	-215.98%	-	-257.95%	-168.20%	100.00%
Operating Margin	-871.19%	-1041.50%	-9526.11%	-1785.27%	-740.03%	-5117.09%
Profit Margin	-1275.88%	-1467.07%	-10315.03%	-5873.14%	-609.23%	-5073.30%
Free Cash Flow Margin	-295.30%	-362.92%	-3833.01%	-1249.98%	-1059.98%	-9168.49%
EBITDA	-2.44	-2.59	-8.44	-4.56	-2.52	-3.81
D&A For EBITDA	0.51	0.52	0.41	0.19	0.14	0
EBIT	-2.95	-3.11	-8.85	-4.74	-2.66	-3.81
Revenue as Reported	0.3	0.3	0.09	-	-	-

Updated Mar 20, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.